Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
about
Neurological immune reconstitution inflammatory response: riding the tide of immune recoveryDrug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis.Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature ReviewImmunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromesCerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathyNatalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosisBroadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyNatalizumab-Related Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome: A Case Report Highlighting Clinical and MRI Features.Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod.Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango.Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literatureImmune reconstitution inflammatory syndrome associated with biologic therapy.Immunology of progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.A case report of simultaneous PML-IRIS during corticosteroids tapering in a patient with an anti-synthetase syndrome.Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin.MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.Neurological safety of fingolimod: An updated reviewJC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.Minimal supportive treatment in natalizumab-related PML in a MS patient.Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
P2860
Q28082309-5BB6B681-5926-4312-A041-3114776F3854Q30815289-4B638781-3597-4F9E-834A-0CEF2445A638Q33573208-FFCB7706-0E58-4975-B1ED-9356B73D882BQ33715659-FF3FE374-719C-426F-959C-BE1E828989BDQ33755345-AD52D8B2-E7D3-4EE4-A664-01446F15166EQ33814485-2DB89737-ABB8-4B92-B945-75B200C48411Q34324861-54D4E8F6-1B0E-4E01-AED1-9DF2A88A4328Q35736438-3A2D78DF-00FE-497F-8DD9-537E9CE7D8DEQ36145715-6271C473-2E7F-4984-BA97-7A7C06F2359CQ36764988-9F8B4141-E9F7-4E6E-AE96-1127C4D137ABQ37403424-2D6E40D8-D53C-46B9-95BE-D2C9096D73E8Q37475542-6C6CFE77-97A6-4C79-8C23-B7FFAAEBF7B8Q37696989-A03FC1AC-10CA-45CD-B697-95482ED911E2Q37697448-AC47255E-C3FD-4840-BB0C-58FD72363E5FQ38163046-C5BAB304-028D-4E9F-BF6D-1CACF14B8245Q38167347-C2C4886E-1DD7-4802-B1B9-5A0E09E8EBADQ38264914-FFB2E89B-15F8-4DBC-8427-1A4E6EB8BD53Q38287572-A3D91871-1938-4DF9-9883-11F6844A4C3AQ38367755-A992D9CA-7458-481A-A7E8-BCDCED06665AQ38462168-69630038-D6E8-49AA-98A8-5E9B9DB44B2FQ38548556-1E6A956D-D7A9-4A8D-A41F-699B0ADF429BQ38558344-5EDC77D3-F0EE-4196-B5CF-4EFF9F4242F4Q38577593-053CCD0B-22A8-4B88-A2E4-81AEE16C9F6BQ38702121-B45FA516-B916-481F-B47B-3C342168D569Q39219113-4A264053-739D-4409-9286-282CC0B626EEQ40619670-EE05B200-7EA8-4FE9-AC6C-538DC90E33EBQ40792696-FFB36D3F-26D6-4E40-BF7B-CF5891DD3996Q41361912-B24A2E47-D10D-4D02-A903-F93A81120FF0Q41553443-4AE712BD-0A73-4B34-8558-F54FA04A8015Q42282868-2575E5D4-1CCC-4F95-A9ED-17823BE5E2EFQ48119795-32A1D11C-24C7-4463-AB27-AB1A5908C99CQ48701158-911D3043-286C-420C-A730-227FCA3A6B12Q52142630-225E5E70-F9B4-43CD-AA20-7345D3CB507EQ52659119-50A97C56-7474-43F4-AFA7-8418709BCAB2Q56448571-33DF2016-6347-42DB-982E-5A5613E39A86
P2860
Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@ast
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@en
type
label
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@ast
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@en
prefLabel
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@ast
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@en
P2093
P2860
P50
P1476
Pathology of immune reconstitu ...... ultifocal leukoencephalopathy.
@en
P2093
Agustin Oterino
Darius Häusler
Ernst-Wilhelm Radue
Francoise Gray
Jens Kuhle
Sven Schippling
Veronika Jakl
Wolfgang Brück
P2860
P2888
P304
P356
10.1007/S00401-011-0900-5
P577
2011-11-06T00:00:00Z